The purpose of this study is to see how safe and tolerable SLGN is, and how well it reduces the amount of hepatitis B virus in people with CHB and HIV. Results from this study could help evaluate whether SLGN can lower the amount of hepatitis B virus in blood and prevent illness in people with CHB and HIV, without the need for life-long therapy. SLGN has not been tested in people with HIV

This study aims to evaluate the usability of the symptom monitoring tool and understand the barriers to completing symptom assessments among patients with chest surgery. Using a symptom monitoring tool, patients will directly report their symptoms to their care team by completing electronic patient-reported outcome (ePRO) assessments.

We are interested in better understanding the experiences of a diverse group of individuals of South Asian descent with their body image and eating patterns, including what factors are associated with body dissatisfaction and disordered eating and which factors may be protective.

Develop a device to measure patient preferences in the treatment of bladder cancer.

This is a study to assess patient, provider, and pharmacist perceptions of delivering FIT kits for colorectal cancer screening in pharmacy settings.

The purpose of this project is to identify and target barriers faced by rural endometrial cancer patients in order to develop a patient navigation intervention. Rural residents with endometrial cancer, the most prevalent gynecologic cancer in the US, have higher odds of mortality than urban endometrial cancer patients. As the number of new endometrial cancer cases is expected to increase 50% by 2030, this urban-rural disparity is expected to continue widening.

The purpose of this study is to understand how the health literacy of a parent or primary caregiver might affect their child's outcomes following a traumatic injury.

Using a semi-structured interview guide, we will conduct formative interviews to better understand nurses' and medical assistants' roles in HPV vaccination.

Purpose:This is a two-arm preliminary efficacy RCT in 120 participants testing a 6-week home-based walking and progressive resistance exercise program (EXCAP©®) vs. standard care on CIPN, interoception, and inflammation. Participants: This study will enroll 120 participants receiving neurotoxic chemotherapy or have completed neurotoxic chemotherapy in the past nine months (i.e., taxane-, platinum-, vinca alkaloid-, epothilone-, or proteasome inhibitor-based chemotherapy). Procedures (methods): Participants will complete questionnaires, clinical assessments, and a blood draw at two time points: pre-intervention (week 0, T1) and post-intervention (approximately week 6, T2).

The purpose of this study is to assess two implementation strategies for the brief alcohol reduction intervention (BAI) for people with HIV (PWH) attending the study ART clinics, and it is designed to help PWH reduce alcohol use and increase ART adherence. As part of this study, you would receive the BAI to assist you with developing skills and strategies to cut down or quit your alcohol use. BAI includes 2 in-person and 2 booster telephone sessions. Face-to-face 45-minute sessions occur ~1 month apart and 10-minute telephone sessions occur 2 to 3 weeks after each face-to-face session.